{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:03:45Z","timestamp":1781280225631,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.yebeh.2024.109774","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T04:53:26Z","timestamp":1713675206000},"page":"109774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Dravet syndrome seizure frequency and clustering: Placebo-treated patients in clinical trials"],"prefix":"10.1016","volume":"155","author":[{"given":"Rima","family":"Nabbout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Hyland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Nortvedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orrin","family":"Devinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2024.109774_b0005","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1750-1172-8-176","article-title":"Encephalopathy in children with dravet syndrome is not a pure consequence of epilepsy","volume":"8","author":"Nabbout","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.yebeh.2024.109774_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core dravet syndrome phenotype","volume":"52","author":"Dravet","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109774_b0015","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1017\/cjn.2016.243","article-title":"Dravet syndrome: diagnosis and long-term course","volume":"43","author":"Conolly","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.yebeh.2024.109774_b0020","first-page":"60","article-title":"Infantile, childhood, and adolescent epilepsies","volume":"22","author":"Wirrell","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.yebeh.2024.109774_b0025","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/brain\/aws151","article-title":"Prognostic, clinical and demographic features in SCN1A mutation-positive dravet syndrome","volume":"135","author":"Brunklaus","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2024.109774_b0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yebeh.2017.05.037","article-title":"Age-related, \u201csleep\/nocturnal\u201d tonic and tonic clonic seizure clusters are underdiagnosed in patients with dravet syndrome","volume":"74","author":"Losito","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.109774_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/S1059-1311(97)80009-X","article-title":"Severe myoclonic epilepsy in infancy: evolution of seizures","volume":"6","author":"Ohki","year":"1997","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2024.109774_b0040","article-title":"Seizure clusters: morbidity and mortality","volume":"12","author":"Baumann","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2024.109774_b0045","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0140-6736(13)60899-5","article-title":"Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study","volume":"382","author":"Fazel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2024.109774_b0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.seizure.2018.05.013","article-title":"Seizure cluster: definition, prevalence, consequences, and management","volume":"68","author":"Jafarpour","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2024.109774_b0055","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/brain\/awn037","article-title":"Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy","volume":"131","author":"Silanp\u00e4\u00e4","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2024.109774_b0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.yebeh.2016.09.007","article-title":"Mortality in dravet syndrome: a review","volume":"64","author":"Shmuely","year":"2016","journal-title":"Epilepsy & Behaviour"},{"key":"10.1016\/j.yebeh.2024.109774_b0065","article-title":"Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe","author":"Cardenal-Munoz","year":"202211","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2024.109774_b0070","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMc1708349","article-title":"Trial of Cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"377","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2024.109774_b0075","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in dravet syndrome: a randomised, double-blind, placebo-controlled trial","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2024.109774_b0080","doi-asserted-by":"crossref","DOI":"10.1007\/s40263-022-00898-1","article-title":"A Practical guide to the treatment of dravet syndrome with anti-seizure Medication","author":"Strzelczyk","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2024.109774_b0085","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamaneurol.2019.4113","article-title":"Fenfluramine for treatment-resistant seizures in patients with dravet syndrome receiving stiripentol-inclusive regimens: a randomized clinical trial","volume":"77","author":"Nabbout","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2024.109774_b0100","year":"2009","journal-title":"CDC Growth Charts"},{"key":"10.1016\/j.yebeh.2024.109774_b0105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1167.2007.01402.x","article-title":"Weight issues for people with epilepsy\u2014A review","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.109774_b0110","series-title":"The Comorbidities of Epilepsy","first-page":"131","article-title":"Chapter 7 - epilepsy and obesity: a complex interaction","author":"Ladino","year":"2019"},{"key":"10.1016\/j.yebeh.2024.109774_b0115","article-title":"Management of Status Epilepticus","volume":"68","author":"Sirven","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.yebeh.2024.109774_b0120","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1371\/journal.pmed.0050166","article-title":"Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy","volume":"5","author":"Rheims","year":"2008","journal-title":"PLoS Med"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024001550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024001550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T04:14:14Z","timestamp":1726373654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505024001550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":22,"alternative-id":["S1525505024001550"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109774","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dravet syndrome seizure frequency and clustering: Placebo-treated patients in clinical trials","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109774"}}